Codexis (CDXS) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Codexis (CDXS) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Codexis |
213.30 Mn |
148.16 Mn |
13.18 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-190.66% |
| Dec 31, 2025 |
148.95% |
| Sep 30, 2025 |
-47.79% |
| Jun 30, 2025 |
35.85% |
| Mar 31, 2025 |
-99.38% |
| Dec 31, 2024 |
49.73% |
| Sep 30, 2024 |
9.29% |
| Jun 30, 2024 |
-97.78% |
| Mar 31, 2024 |
-59.97% |
| Dec 31, 2023 |
79.40% |
| Sep 30, 2023 |
-202.94% |
| Jun 30, 2023 |
49.05% |
| Mar 31, 2023 |
-79.44% |
| Dec 31, 2022 |
-26.14% |
| Sep 30, 2022 |
-278.48% |
| Jun 30, 2022 |
68.41% |
| Mar 31, 2022 |
18.00% |
| Dec 31, 2021 |
-554.10% |
| Sep 30, 2021 |
152.61% |
| Jun 30, 2021 |
52.97% |
